Researchers got the immune-boosting results they wanted from Moderna's vaccine candidate


The results from the first phase of Moderna's coronavirus vaccine trial are out, and the promising findings are in line with some early data from the study released in May.
The study, published Tuesday in The New England Journal of Medicine, found the experimental mRNA vaccine — which requires two doses a month apart — induced coronavirus immune responses in all 45 participants, just as scientists had hoped. There were some mild side effects, including fatigue, chills, and fevers, but The Associated Press notes those aren't uncommon with other vaccines, and there have been no major safety concerns.
Moderna will begin its final step at the end of July, a 30,000-person study to prove if the shots are strong enough to protect people from the virus. While the first phase does indicate the vaccine produces antibodies geared toward fighting off the virus, it's less clear if the levels of antibodies are enough to actually fend off infection. Read the full results of the study at The New England Journal of Medicine, as well as more context at The Associated Press.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
May 24 editorial cartoons
Cartoons Saturday's political cartoons feature Medicare and Medicaid cuts, James Comey's social media post, and Trump's big beautiful bill.
-
5 cartoons about the Russia-Ukraine peace talks
Cartoons Artists take on a stand-in for Vladimir Putin and phone calls with Donald Trump.
-
Donald Trump's foreign policy flip in the Middle East
Talking Point Surprise lifting of sanctions on Syria shows Saudi Arabia, the UAE and Qatar are now effectively 'dictating US foreign policy'
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County